格特隐球菌临床表现与结局的预测因素:一项国际研究
该回顾性队列研究纳入1999至2011年澳大利亚、加拿大和美国报告的258例格特隐球菌病例,分析感染部位和住院病例(N=218)死亡的相关因素。VGI谱系感染与中枢神经系统和/或其他肺外疾病风险升高相关,而年龄≥70岁、慢性肺病和免疫抑制状态与死亡率升高相关,菌种和谱系与死亡风险无关。
要点
- VGI谱系感染与中枢神经系统和/或其他肺外疾病风险升高相关(aOR=9.21)。
- 年龄≥70岁、慢性肺病和免疫抑制状态与格特隐球菌死亡率升高相关。
- 格特隐球菌菌种和谱系与感染部位相关,但与死亡风险无关。
核心结论
- 在住院病例中,格特隐球菌菌种和谱系与感染部位相关,但与死亡风险无关,而年龄较大和合并症增加死亡风险。
研究设计与样本
- 回顾性队列研究,提取1999至2011年澳大利亚、加拿大和美国报告的258例格特隐球菌病例数据,对住院病例(N=218)进行未调整和多变量逻辑回归分析。
主要发现
- 住院格特隐球菌病例中,中枢神经系统和其他肺外疾病患者较肺部疾病患者更年轻、更可能居住在澳大利亚、更可能感染variety gattii I(VGI)谱系,但较少有合并症且较少死亡。
- VGI感染病例发生中枢神经系统和/或其他肺外疾病的比值高9倍(aOR=9.21,95%CI=3.28-25.89)。
- 年龄≥70岁(aOR=6.69,95%CI=2.44-18.30)、慢性肺病(aOR=2.62,95%CI=1.05-6.51)和免疫抑制状态(aOR=2.08,95%CI=1.05-6.51)与格特隐球菌死亡率升高相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infection by Cryptococcus gattii can lead to pulmonary or central nervous system (CNS) disease, or both. Whether the sites of infection and disease severity are associated with C. gattii species and lineages or with certain underlying medical conditions, or both is unclear. We conducted a retrospective cohort study to identify factors associated with site of infection and mortality among C. gattii cases. METHODS: We extracted data on 258 C. gattii cases from Australia, Canada, and the United States reported from 1999 to 2011. We conducted unadjusted and multivariable logistic regression analyses to evaluate factors associated with site of infection and C. gattii mortality among hospitalized cases (N = 218). RESULTS: Hospitalized C. gattii cases with CNS and other extrapulmonary disease were younger, more likely to reside in Australia, and be infected with variety gattii I (VGI) lineage but less likely to have comorbidities and die as compared to cases with pulmonary disease. The odds of having CNS and/or other extrapulmonary disease were 9 times higher in cases with VGI infection (adjusted odds ratio [aOR] = 9.21, 95% confidence interval [CI] = 3.28-25.89). Age ≥70 years (aOR = 6.69, 95% CI = 2.44-18.30), chronic lung disease (aOR = 2.62, 95% CI = 1.05-6.51) and an immunocompromised status (aOR = 2.08, 95% CI = 1.05-6.51) were associated with higher odds of C. gattii mortality. CONCLUSIONS: Among hospitalized cases, C. gattii species and lineage are associated with site of infection but not with the risk of death, whereas older age and comorbidities increase the risk of death.
引用
- Galanis E, MacDougall L, Rose C, et al. Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study. Clin Infect Dis. 2025. PMID: 39774783. doi:10.1093/cid/ciae640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。